BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 8862634)

  • 1. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
    Wulfsberg EA
    Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Williams syndrome cognitive profile also characterizes Velocardiofacial/DiGeorge syndrome.
    Bearden CE; Wang PP; Simon TJ
    Am J Med Genet; 2002 Aug; 114(6):689-92. PubMed ID: 12210289
    [No Abstract]   [Full Text] [Related]  

  • 4. Autosomal dominant "Opitz" GBBB syndrome due to a 22q11.2 deletion.
    McDonald-McGinn DM; Emanuel BS; Zackai EH
    Am J Med Genet; 1996 Aug; 64(3):525-6. PubMed ID: 8862635
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microdeletion of 22q11, DiGeorge and velocardiofacial syndrome].
    Hjalgrim H; Hahnemann JM; Timshel S; Brøndum-Nielsen K
    Ugeskr Laeger; 2000 Jul; 162(31):4169-70. PubMed ID: 10962926
    [No Abstract]   [Full Text] [Related]  

  • 6. [Transient neonatal hypocalcemia. Onset Manifestation of the 22q11.2 deletion syndrome].
    Pusceddu M; Bertone A; Campra D; Pontoriero D; Guala A
    Minerva Pediatr; 2002 Aug; 54(4):343-5. PubMed ID: 12131871
    [No Abstract]   [Full Text] [Related]  

  • 7. Velocardiofacial syndrome (Shprintzen syndrome, chromosome 22q11 deletion syndrome).
    Olney AH; Kolodziej P
    Ear Nose Throat J; 1998 Jun; 77(6):460-1. PubMed ID: 9674319
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. A review.
    Demczuk S; Aurias A
    Ann Genet; 1995; 38(2):59-76. PubMed ID: 7486827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A region of homozygosity within 22q11.2 associated with congenital heart disease: recessive DiGeorge/velocardiofacial syndrome?
    Henwood J; Pickard C; Leek JP; Bennett CP; Crow YJ; Thompson JD; Ahmed M; Watterson KG; Parsons JM; Roberts E; Lench NJ
    J Med Genet; 2001 Aug; 38(8):533-6. PubMed ID: 11494964
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.
    D'Antoni S; Mattina T; Di Mare P; Federico C; Motta S; Saccone S
    Gene; 2004 May; 333():111-9. PubMed ID: 15177686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size of 22q deletions in four previously reported patients with conotruncal anomaly face syndrome.
    Pierpont JW; Erickson RP; Thompson FH; Yang JM
    Clin Genet; 1996 Dec; 50(6):545-7. PubMed ID: 9147896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
    McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
    Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis of DiGeorge and velocardiofacial syndromes.
    Driscoll DA
    Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kabuki syndrome is not caused by a microdeletion in the DiGeorge/velocardiofacial chromosomal region within 22q 11.2.
    Li M; Zackai EH; Niikawa N; Kaplan P; Driscoll DA
    Am J Med Genet; 1996 Oct; 65(2):101-3. PubMed ID: 8911598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient with a 22q11.2 deletion with no overlap of the minimal DiGeorge syndrome critical region (MDGCR).
    McQuade L; Christodoulou J; Budarf M; Sachdev R; Wilson M; Emanuel B; Colley A
    Am J Med Genet; 1999 Sep; 86(1):27-33. PubMed ID: 10440825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 22q11.2 deletion syndrome.
    Emanuel BS; McDonald-McGinn D; Saitta SC; Zackai EH
    Adv Pediatr; 2001; 48():39-73. PubMed ID: 11480765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective.
    Cable BB; Mair EA
    Ear Nose Throat J; 2003 Jan; 82(1):56-60. PubMed ID: 12610907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.